Ring Chromosome 20 syndrome, also known as r(20), is an ultra-rare condition, the first symptom of which is usually epilepsy. Due to the delayed onset of the signs of the syndrome and the difficulties in identifying it, no true statistics for r(20) exist. This isn’t good enough for Allison Watson, co-founder of Ring20 Research & Support UK CIO. Here, she explains why.
Epihunter is used by children, young people, and adults. In this interview, we meet Philippe (52) from Antwerp, Belgium. He has been using Epihunter for some time and shares his story with us - from his first seizure to his new daily approach and the lessons of his epilepsy.
Do you remember the 1990s? At that time the main reasons for having a mobile phone were calling, texting, and playing Snake. Today, we use our phone to track our diet, to measure our heart rate, and to plan our rehabilitation. Our international sales and community manager, Hogne, dives into the topic of ‘Mobile Health’.
Epihunter as a promising Health Tech solutions provider
About 4 months ago Epihunter won the Jury award for Innovation at Health&Care 2018. End of June we presented our solution at the Healthtech Summit in Lausanne after being nominated by industry as one of the 40 most promising health tech startups in Europe. All this is linked to our mission to create digital solutions to make epilepsy matter less, and to our belief that current digital technologies can create a massive impact on the daily life of people with epilepsy.